Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea

NCT02067676 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

FED

Sponsor class

Conditions

Campylobacter Infection

Interventions

BIOLOGICAL: Capsule-Conjugate Campylobacter Vaccine (CJCV1)
DRUG: Alhydrogel®, aluminum hydroxide adjuvant (alum)

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]